マルチアセンストリーメタアナリシスは,既知のおよび新しいロシオでのアルツハイマー病の発症年齢の遺伝子変異因子を特定します
Elizabeth E Blue1,2,3, Jai Broome1,4, Diane Xue2,5
1Department of Medicine, Division of Medical Genetics, University of Washington, Seattle, Washington, USA.
まとめ
この研究では,さまざまな集団におけるアルツハイマー病 (AD) の発症年齢 (AAO) に影響する新しい遺伝的要因が特定されました. アポリポプロテインE (APOE) の調整は,ADにおけるその役割を強調し,遺伝的発見に大きく影響した.
科学分野:
- 遺伝学
- 神経科学
- 人口の健康
背景:
- アルツハイマー病 (AD) のリスクは,年齢,アポリプロテインE (APOE) の遺伝子型,および性別によって影響されます.
- 発症時のAD年齢 (AAO) の遺伝的変容因子は,特に多様な祖先では完全に理解されていません.
研究 の 目的:
- 多種多様な集団におけるAD AAOの遺伝子変形剤を特定する.
- 性別とAPOEがこれらの遺伝的関連に及ぼす影響を調査する.
- ヨーロッパの祖先に焦点を当てた以前の大規模な研究と比較してください.
主な方法:
- 2つの異なるサンプルでAAOの全ゲノム関連研究 (GWAS) を実施した.
- 性別とAPOEを調整したメタアナリシス
- 生存分析を用いて,p < 5x10^-8 で全ゲノムにわたる有意性を設定した.
主要な成果:
- 既知のADリスクロシオと4つの新しいシグナルを含む17の重要なロシオが特定されました.
- APOEの調整は,ゲノム全体のGWAS効果のサイズに大きな影響を与えた.
- 性別調整はGWASの結果に最小限の影響を及ぼした.
結論:
- ADAAOの新たな遺伝子変形剤を発見した. 多様で小さいサンプルでも.
- 以前ヨーロッパ系のみのGWASで見つかった複製ロシ.
- バイナリ診断特性を上回る遺伝的発見のための定量的な特徴としてAAOの有用性を示した.
さらに関連する動画
関連する概念動画
Alzheimer's Disease: Overview
666
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
666
Human Genetics
716
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...
716
Genome-wide Association Studies-GWAS
14.1K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
14.1K
Alzheimer's Disease: Treatment
260
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
260


